Home
Reed Smith
Kelly A. Kearney
Kelly A. Kearney
Reed Smith
At Long Last: FDA Publishes Draft Guidance On The Prohibition On Wholesaling Under Section 503B Of The FDCA
05 Jul 2023 | United States
FDA Finalizes Determinations On 11 Bulk Drug Substances On 503B Bulks List
26 Jun 2023 | United States
Open For Business In 2021
14 Dec 2020 | United States
CMS Releases Roadmap For States To Accelerate Adoption Of Value-based Care
21 Sep 2020 | United States
Reliance On Telehealth Ramps Up During COVID-19, And May Be Here To Stay
29 Jun 2020 | United States
FDA Publishes New Draft Guidance On Animal Drug Compounding
29 Nov 2019 | United States
The Drug Enforcement Administration Amends Regulations Applicable To Registrants Ordering Certain Controlled Substances
06 Nov 2019 | United States
FDA Partners With The National Association Of Boards Of Pharmacy To Create An Information-Sharing System For Drug Compounding Activities
17 Oct 2019 | United States
Outsourcing Facility Athenex Withdraws Appeal Of District Court's Ruling On FDA's Placement Of Bulk Drug Substances On Its "Clinical Need" List
07 Oct 2019 | United States
Recent Traction In FDA's Development Of The 503A And 503B Bulks Lists
11 Sep 2019 | United States
FDA Issues 2019 Goals To Improve The Quality Of Compounded Drugs
26 Apr 2019 | United States
To Close Out 2018, FDA Published A Revised Draft Guidance On Human Drug Compounding For Outsourcing Facilities
01 Feb 2019 | United States
Record and Data Management Alert
13 May 2004 | United States
Contact Details
Pittsburgh
Pittsburgh
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.